Overall Survival
45
6
10
10
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.2%
1 terminated out of 45 trials
90.9%
+4.4% vs benchmark
9%
4 trials in Phase 3/4
0%
0 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (45)
Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma
Pooled Analysis of Patients With Early-stage Breast Cancer Treated With Adjuvant Dose-dense Sequential Chemotherapy: a Hellenic Cooperative Oncology Group (HeCOG) Study.
Long-term Follow-up of Subjects Treated With CAR T Cells
Efficacy of Dose-Adjusted Regimen on Survival in Frail Adults With Acute Lymphoblastic Leukemia
Intraoperative Blood Pressure Management and Dexamethasone in Lung Cancer Surgery
Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery
Dexmedetomidine and Outcomes of Elderly Admitted to ICU After Surgery
Multi-Center Study Protocol: Impact of Sarcopenia in Early-Onset Colorectal Cancer.
DataBase for Analysis of Rectal Cancer Oncological Results
Mesenteric Lymph Node Metastasis and Nutritional Status After Bowel Resection for Ovarian Cancer
Microwave Ablation Versus Liver Resection for Intrahepatic Cholangiocarcinoma
Id and Rd Maintenance Regimens After Induction of Remission in Multiple Myeloma.
A Novel Target Delineation Scheme in High-grade Glioma Patients: a Randomized Single-blind Clinical Trial
Efficacy of Chemopreventive Agents on Disease-free and Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma: The CAOS Study
Microwave Ablation Versus Laparoscopic Hepatectomy for 3-5cm Hepatocellular Carcinoma
Real-world Study for Patients With Advanced Hepatobiliary Tumors
Anlotinib Plus PD-1 Inhibitor as 2nd-line Threapy in Patients With Metastatic Pancreatic Cancer
Study of Irinotecan,Oxaliplatin, and S1 in Patients With Advanced Pancreatic Cancer
Irinotecan and Anlotinib for Epithelioid Sarcoma
Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer